Department of Pharmaceutical Sciences

Seminars from Previous Semesters

Seminar Schedule: Spring '02

All seminars held on Thursdays, between 5.00pm and 6:20pm, in Room COOKE 121 unless noted otherwise. Refreshments served at 4:50 P.M.

Jan. 16	PW Nathanielsz, Cornell University Fetal Glucocorticoids: Can you have too much of a good thing?
Jan. 17	Lee Jia, Inst. Drug Development/ Cancer Therapy & Res. Center, San Antonio, TX Nitric Oxide Research: From hypothesis to drug development
Jan. 24	Prof. Mike Brattain, Chair, Department of Pharmacology, RPCI, Buffalo Therapy and Cancer
Jan. 31	Dr. Roh-Yu Shen, Research Institute on Addictions, Buffalo Changes in the activity of dopamine neurons after prolonged ethanol exposure
Feb. 7	Mr. Donny Tran, Graduate Student, Dept of Pharmaceutical Sciences, University at Buffalo-SUNY Nitrite inhalant exposure alters expression of cancer/angiogenesis genes
Feb. 14	Seong Hoon Jang, Ohio State University Intracellular pharmacokinetics of paclitaxel: Relationship with pharmacodynamics and therapeutic implication
Feb. 14	Dr. Kathleen McCormick, Asst. Professor, Dept. of Physical Therapy, University at Buffalo-SUNY Myocardial growth in IGF2/M6P receptor-null mice
Feb. 21	Mr. Carl Raimond, Accounts Manager, Affymetrix Inc Affymetrix Genechips: Overview and the new innovations in Genechip technology
Feb. 28	Ms. Xiao-Fei Zhou, Graduate Student, Dept of Pharmaceutical Sciences, University at Buffalo-SUNY Hydropyridine and dihydropyridine as modulators of P-glycoprotein and MRR1 - mediated efflux
Mar. 7	Ms. Jin Chen, Graduate Student, Dept of Pharmaceutical Sciences, University at Buffalo-SUNY Inverse targeting of Topotecan in IP therapy using topotecan antibodies
Mar. 14	Dr David G. Hangauer, Assoc. Professor, Dept. of Chemistry, University at Buffalo-SUNY Rational design, synthesis and testing of protein kinase inhibitors
Mar. 21	Dr Ping Liang, Asst. Professor, Department of Cancer Genetics, RPCI, Buffalo Applications of bioinformatics and comparative genomics in gene discovery
Mar. 27	Samuel J. Costanzo, Proctor & Gamble HPLC and the method development cycle
Mar. 28	No Seminar-- Spring Recess
Apr. 4	Mr. Donald Mager, Graduate Student, University at Buffalo-SUNY Target-Mediated Drug Disposition and Dynamics
Apr. 4	Mr. Adam Persky, Graduate Student, University of Florida Steady-state pharmacokinetics of creatine monohydrate
Apr. 5	Javier Blanco, St. Jude's Hospital Topoisomerase II inhibitor-related myeloid leukemia: Identification of risk factors
Apr. 11*	Prof. Kathy Giacomini, Prof. Levy Distinguished Lecture Series, UCSF CA Pharmaceutical sciences in the new millennium: Human genetics converges with pharmacokinetics and pharmacodynamics
Apr. 11	Ms. Jintana Napaporn, Graduate Student, University of Florida Electrophysiological characterization of nociceptive-mediated injection pain
Apr. 18	Dr Lawrence J. Lesko, Director, Office of Clinical Pharmacology and Biopharmaceutics, FDA, Maryland Pharmacogenomic- and Pharmacogenetic-Guided Drug Development
Apr. 25	Ms. Roseane Santos, Graduate Student, Dept of Pharmaceutical Sciences, University at Buffalo-SUNY Gene expression patterns for treatment effects in Multiple Sclerosis
May 2	Mr. Rusty Arnold, Graduate Student, Dept of Pharmaceutical Sciences, University at Buffalo-SUNY Doxorubicin liposome mediated alteration in tumor vascular permeability
May 6	Mr. Ryan Hansen, Graduate Student, Dept of Pharmaceutical Sciences, University at Buffalo-SUNY Intravenous immunoglobulin effects in experimental models of immune thrombocytopenia
May 6	Thaddeus Grasela, Cognigen Corporation Cognitive engineering in modern drug development
May 8	Candace S Johnson, Roswell Park Cancer Institute, Buffalo Aniproliferataive activities of 1,25 dihydroxycholecalciferal: In vitro and in vivo studies

* Special Timing - All school conference hour For more information:

Dr. S. V. Balasubramanian, Seminar Chair: svb@acsu.buffalo.edu

Last Modified: Wednesday, 11-Oct-2006 10:24:52 EDT